Literature DB >> 8612254

Opportunity lost: a frontline view of reference-based pricing.

R F Woollard.   

Abstract

The introduction in October 1995 of reference-based pricing as a cost-saving measure for British Columbia's drug benefit program represented an opportunity for collaboration between frontline practitioners and the bureaucracy that supports some of their work. If well-established principles of continuing education, quality improvement and modern management had been followed, practitioners in the field could have focused their individual and collective talents effectively and constructively on the task of improving cost-effectiveness in drug prescribing. Although the reference-based pricing program may well achieve its purpose of saving money, it is sad that it was not used to build bridges of common interest and mutual trust between two camps that are often in conflict.

Entities:  

Mesh:

Year:  1996        PMID: 8612254      PMCID: PMC1487670     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  4 in total

1.  Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section.

Authors:  J Lomas; M Enkin; G M Anderson; W J Hannah; E Vayda; J Singer
Journal:  JAMA       Date:  1991-05-01       Impact factor: 56.272

2.  Evaluation of an educational program for primary care practitioners, on the management of osteoarthritis.

Authors:  J K Stross; G G Bole
Journal:  Arthritis Rheum       Date:  1985-01

Review 3.  Improving physician prescribing practices: bridge over troubled waters.

Authors:  S M MacLeod
Journal:  CMAJ       Date:  1996-03-01       Impact factor: 8.262

4.  Evaluation of a continuing education program in rheumatoid arthritis.

Authors:  J K Stross; G G Bole
Journal:  Arthritis Rheum       Date:  1980-07
  4 in total
  6 in total

1.  Evaluating reference-based pricing: initial findings and prospects.

Authors:  L Narine; M Senathirajah; T Smith
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

Review 2.  Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients.

Authors:  D B Hogan
Journal:  CMAJ       Date:  1997-10-15       Impact factor: 8.262

3.  Reference-based pricing: will other provinces follow the BC lead?

Authors:  A Mullens
Journal:  CMAJ       Date:  1998-01-27       Impact factor: 8.262

4.  Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.

Authors:  P V Grootendorst; L R Dolovich; B J O'Brien; A M Holbrook; A R Levy
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

5.  Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.

Authors:  C Bourgault; E Elstein; J Le Lorier; S Suissa
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

6.  Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.

Authors:  Jennifer M Polinski; Malcolm Maclure; Blair Marshall; Alan Cassels; Jessica Agnew-Blais; Amanda R Patrick; Sebastian Schneeweiss
Journal:  Can J Clin Pharmacol       Date:  2008-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.